Celebrating a Remarkable Career Milestone for Advances in IBD Co-Chair Dr. Miguel Regueiro
Today, the Advances in IBD community proudly recognizes an extraordinary career milestone for longtime Co-Chair Dr. Miguel Regueiro, who has been promoted to Executive Vice President and Enterprise Chief of Staff at Cleveland Clinic.
The appointment reflects Dr. Regueiro's decades of leadership, clinical excellence, and dedication to advancing patient care. It also represents a well-deserved recognition of the impact he has made throughout his career as a physician, educator, researcher, and leader in the field of gastroenterology.
While this achievement marks an exciting new chapter in his career, it also provides an opportunity for the Advances in IBD community to reflect on the tremendous impact Dr. Regueiro has had on the field of inflammatory bowel disease and on the conference itself.
Dr. Regueiro has served as Co-Chair of Advances in IBD, helping guide the conference's growth into one of the premier educational meetings dedicated to inflammatory bowel disease. Through his leadership, vision, and commitment to excellence, he has played a pivotal role in shaping the educational experience for thousands of healthcare professionals who attend the meeting each year.
As Co-Chair, Dr. Regueiro has been instrumental in developing the conference agenda, ensuring that attendees receive timely, evidence-based education that addresses the most important clinical challenges and emerging advances in IBD care. His ability to identify critical topics, engage leading experts, and foster meaningful discussion has helped establish Advances in IBD as a trusted forum for learning, collaboration, and innovation.
Beyond his contributions to the conference program, Dr. Regueiro has helped influence generations of IBD clinicians through his dedication to education and mentorship. His passion for advancing the field has inspired countless physicians, advanced practice providers, fellows, and other healthcare professionals committed to improving outcomes for patients living with Crohn's disease and ulcerative colitis.
Throughout his career, Dr. Regueiro has been widely recognized for his expertise in inflammatory bowel disease and his commitment to improving patient care through clinical practice, research, and education. His work has helped advance the understanding and management of IBD while contributing to the continued evolution of multidisciplinary care for patients around the world.
For those who have attended Advances in IBD over the years, Dr. Regueiro's impact extends well beyond the podium. His thoughtful leadership, dedication to scientific rigor, and commitment to bringing together the brightest minds in IBD have helped define the character and mission of the conference.
As the Advances in IBD community celebrates this well-deserved achievement, we are grateful for Dr. Regueiro's longstanding contributions to the meeting and to the field of gastroenterology. We are equally pleased that he will continue serving as Co-Chair of Advances in IBD, helping guide the conference and inspire future generations of IBD clinicians.
On behalf of the Advances in IBD faculty, attendees, and broader IBD community, we extend our sincere congratulations to Dr. Regueiro on this remarkable accomplishment and wish him continued success in his new leadership role at Cleveland Clinic.